Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This molecule is a natural antisense non-coding RNA transcript complementary to the SPIN1 (Spindlin 1) gene. NATs like ENSG00000287769 are transcribed from the DNA strand opposite a protein-coding gene and are implicated in the regulation of gene expression, chromatin state, and mRNA processing. Although such transcripts can influence biological processes including cell proliferation and disease pathways, the specific regulatory roles, functional significance, and therapeutic potential of the "novel transcript, antisense to SPIN1" have not been experimentally elucidated as of the time of writing. It remains primarily a research interest, not a conventional therapeutic target[1][3][5][7][8][9].
Not established. General mechanisms for antisense transcripts involve RNA-based regulation, but no agents targeting this specific NAT are known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to Spindlin 1 (ENSG00000287769).